These results suggest that the H&E-ERBB2 score is a predictor of ERBB2 status as determined by CISH and that the model generalizes from small tumor areas (tissue microarray spots) to whole-slide samples from an independent test cohort. The gene discussed is ERBB2; the disease is neoplasm.